Royal Bank of Canada’s Elanco Animal Health ELAN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.62M | Sell |
151,057
-6,699
| -4% | -$164K | ﹤0.01% | 2654 |
|
|
2025
Q4 | $3.57M | Sell |
157,756
-947,256
| -86% | -$20.6M | ﹤0.01% | 2696 |
|
|
2025
Q3 | $22.3M | Buy |
1,105,012
+598,553
| +118% | +$10M | ﹤0.01% | 1564 |
|
|
2025
Q2 | $7.23M | Buy |
506,459
+258,000
| +104% | +$3.02M | ﹤0.01% | 2277 |
|
|
2025
Q1 | $2.61M | Buy |
248,459
+108,644
| +78% | +$1.23M | ﹤0.01% | 2757 |
|
|
2024
Q4 | $1.69M | Sell |
139,815
-188,503
| -57% | -$2.47M | ﹤0.01% | 3129 |
|
|
2024
Q3 | $4.82M | Sell |
328,318
-153,584
| -32% | -$2.14M | ﹤0.01% | 2310 |
|
|
2024
Q2 | $6.95M | Buy |
481,902
+9,634
| +2% | +$154K | ﹤0.01% | 1932 |
|
|
2024
Q1 | $7.69M | Buy |
472,268
+172,338
| +57% | +$2.69M | ﹤0.01% | 1881 |
|
|
2023
Q4 | $4.47M | Buy |
299,930
+85,803
| +40% | +$972K | ﹤0.01% | 2345 |
|
|
2023
Q3 | $2.41M | Buy |
214,127
+174,484
| +440% | +$2.03M | ﹤0.01% | 2695 |
|
|
2023
Q2 | $399K | Sell |
39,643
-28,807
| -42% | -$267K | ﹤0.01% | 4123 |
|
|
2023
Q1 | $644K | Sell |
68,450
-2,251,689
| -97% | -$26.6M | ﹤0.01% | 3663 |
|
|
2022
Q4 | $28.4M | Buy |
2,320,139
+1,036,130
| +81% | +$12.9M | 0.01% | 950 |
|
|
2022
Q3 | $15.9M | Sell |
1,284,009
-930,534
| -42% | -$16.3M | 0.01% | 1213 |
|
|
2022
Q2 | $43.5M | Buy |
2,214,543
+231,806
| +12% | +$5.49M | 0.01% | 707 |
|
|
2022
Q1 | $51.7M | Sell |
1,982,737
-888,850
| -31% | -$23.7M | 0.01% | 730 |
|
|
2021
Q4 | $81.5M | Buy |
2,871,587
+673,882
| +31% | +$21M | 0.02% | 602 |
|
|
2021
Q3 | $70.1M | Buy |
2,197,705
+400,689
| +22% | +$13.4M | 0.02% | 617 |
|
|
2021
Q2 | $62.3M | Buy |
1,797,016
+252,584
| +16% | +$8.33M | 0.02% | 642 |
|
|
2021
Q1 | $45.5M | Buy |
1,544,432
+85,493
| +6% | +$2.63M | 0.01% | 747 |
|
|
2020
Q4 | $44.7M | Buy |
1,458,939
+294,514
| +25% | +$8.99M | 0.01% | 755 |
|
|
2020
Q3 | $32.5M | Buy |
1,164,425
+19,085
| +2% | +$484K | 0.01% | 801 |
|
|
2020
Q2 | $24.6M | Buy |
1,145,340
+753,359
| +192% | +$16.6M | 0.01% | 929 |
|
|
2020
Q1 | $8.78M | Buy |
391,981
+3,273
| +0.8% | +$89.6K | ﹤0.01% | 1448 |
|
|
2019
Q4 | $11.4M | Sell |
388,708
-31,146
| -7% | -$846K | ﹤0.01% | 1539 |
|
|
2019
Q3 | $11.2M | Sell |
419,854
-287,737
| -41% | -$8.63M | ﹤0.01% | 1486 |
|
|
2019
Q2 | $23.9M | Buy |
707,591
+66,859
| +10% | +$2.17M | 0.01% | 970 |
|
|
2019
Q1 | $20.5M | Buy |
640,732
+388,358
| +154% | +$12M | 0.01% | 1048 |
|
|
2018
Q4 | $7.96M | Sell |
252,374
-22,812
| -8% | -$747K | ﹤0.01% | 1659 |
|
|
2018
Q3 | $9.52M | Buy |
+275,186
| New | +$9.68M | ﹤0.01% | 1647 |
|
Other funds holding ELAN
VPM
VCM
Royal Bank of Canada's ELAN Position: Q1 2026 in Review
Royal Bank of Canada reduced its Elanco Animal Health (ELAN) stake by 4.2% in Q1 2026, selling an estimated $164K and leaving 151,057 shares worth $3.62M. The position accounts for ﹤0.01% of the portfolio, ranked #2654.
Royal Bank of Canada first reported a position in ELAN in Q3 2018 and has held it in 31 quarters since. The position peaked at $81.5M in Q4 2021. 516 funds tracked by Wall St. Rank hold ELAN as of Q1 2026.
- Royal Bank of Canada held 151,057 shares of Elanco Animal Health worth $3.62M as of Q1 2026.
- Royal Bank of Canada sold 6,699 Elanco Animal Health shares in Q1 2026, an estimated $164K.
- Elanco Animal Health made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #2654 holding.
- Royal Bank of Canada first reported a position in Elanco Animal Health in Q3 2018 and has held it in 31 quarters since.
- Royal Bank of Canada's Elanco Animal Health position peaked at $81.5M in Q4 2021.
- 516 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2026.
Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.